Previous 10 | Next 10 |
Merger activity remained steady last week. Two of the largest deals of this year were announced last week. SPAC activity continues to grow at a steady pace. For further details see: Merger Arbitrage Mondays - Coherent Shareholders Delighted By Another Round Of Counteroff...
Aytu BioScience (AYTU) announces the closing of its $44.9M merger with Neos Therapeutics, with Neos merging with a wholly-owned subsidiary of Aytu.The combined company has begun operating under the name Aytu BioPharma, and its shares will continue to trade on Nasdaq under the ticker...
Are These The Top Biotech Stocks to Buy Right Now? Biotech stocks have been a hot topic among investors these days. This comes as the U.S. undergoes mass vaccination against the coronavirus. Investors are always on the lookout for top biotech stocks that could be the next big th...
Gainers: Neos Therapeutics (NEOS) +17%,Aytu BioScience (AYTU) +14%, Vericel (VCEL) +14%, Brickell Biotech (BBI) +14%, Infinity Pharmaceuticals (INFI) +13%.Losers: Translate Bio (TBIO) -32%, ContraFect (CFRX) -13%, Lipocine (LPCN...
BioHiTech Global (BHTG) +44% on receiving $2M in Digester orders.Upstart Holdings (UPST) +39% on Q4 results.Neos Therapeutics (NEOS) +30%.Seneca Biopharma (SNCA) +26%.Evolving Systems (EVOL) +24% on Q4 results.Can-Fite BioPharma (CANF) +17% on announcing new data from a pr...
Penny Stock News Triggers Momentum In These Cheap Stocks When it comes to penny stocks, there are plenty of different catalysts to consider. You could look for general market trends or sector/industry-based themes. However, these are more along the line of technical catalysts. On the ot...
Merger activity decreased last week with four new deals announced. Coherent and Aegion receive rival bids. Athene Holding to merge with Apollo Global Management. For further details see: Merger Arbitrage Mondays - Bidding Wars And Revised Agreements
Initial details from the FDA-approved trial for the Healight medical device published by Cedars-Sinai show that UVA therapy may be a safe and effective treatment for severe SARS-CoV-2 infection. Cedars-Sinai and Aytu BioScience are working with the FDA to confirm the next steps on the...
Best Biotech Stocks To Buy [Or Sell] This Month Biotech stocks are still in focus today amidst the sell-off that has been happening in recent weeks. Regardless if these companies are working on coronavirus treatment like Moderna ( NASDAQ: MRNA ) or making revolutionary thera...
AnPac Bio-Medical Science (ANPC) +75% after update on cancer detection system CDAPS.Second Sight Medical Products (EYES) +67%.GT Biopharma (GTBP) +45%.Auris Medical Holding Ltd. (EARS) +24%.Taoping Inc. (TAOP) +10% on launching Blockchain Business Division.AirNet Technology (ANTE) +...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...